Beaufort CRO provides clinical research organization services including clinical trial management, data management, biostatistics, regulatory affairs, and quality assurance. They support clients with in vitro diagnostics and medical device development.

Beaufort CRO

Allucent provides strategies and solutions for small to mid-sized biotech companies, assisting in the clinical development process from therapeutic innovations through regulatory approval.

Allucent

BioRankings provides data analyses, consulting, and software to researchers in life sciences. The team offers services such as statistical protocol development, applied data analysis, and clinical trial support, among others.

BioRankings

Interactive Brokers Group, Inc. operates as an automated electronic broker worldwide. The company specializes in executing, clearing, and settling trades in stocks, options, futures, foreign exchange instruments, bonds, mutual funds, exchange traded funds (ETFs), metals, and cryptocurrencies. It also custodies and services accounts for hedge and mutual funds, ETFs, registered investment advisors, proprietary trading groups, introducing brokers, and individual investors. In addition, it offers custody, prime brokerage, securities, and margin lending services. The company serves institutional and individual customers through approximately 150 electronic exchanges and market centers. Interactive Brokers Group, Inc. was founded in 1977 and is headquartered in Greenwich, Connecticut.

Metric
Company Name	Beaufort CRO	Allucent	BioRankings	Interactive Brokers Group, Inc.
Symbol				IBKR
MSH ID	COM:BEAUFORTCRO	COM:ALLUCENT	COM:BIORANKINGS	COM:INTERACTIVEBROKERS
Market	PRIVATE	PRIVATE	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Healthcare & Health Services	Commercial & Professional Services	Financial Services
Industry	Clinical Research	Biotechnology	Healthcare & Health Services	Financial - Capital Markets
Country	US	US	US	US
Stage
Employee Count				2.95K
Website	beaufortcro.com	allucent.com	biorankings.com	interactivebrokers.com
LinkedIn				interactive-brokers
Founders

Metric
Market Cap		13.37B
Enterprise Value
Monthly Web Traffic	352	11.69M
Web Traffic Growth	-0.73	0.23
Valuation
Raised Capital

Metric
Revenue				7.86B
Revenue (LTM)
Revenue (NTM)
Gross Profit				7.38B
EBITDA				6.68B
Operating Income				6.58B
Net Income				600M
EPS				5.72
Diluted EPS				5.67
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin				1
Operating Profit Margin				0.94
EBITDA Margin				0.85
Net Profit Margin				0.29
Return on Equity				0.19
Return on Assets				0.01
Return on Capital Employed				0.41

COM:BEAUFORTCRO

Beaufort CRO

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio				17.75
P/B Ratio				3.02
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio				8.45
EV Multiple				232.28

Metric
Days Sales Outstanding				3.45K
Days Payables Outstanding				8.87K
Days Inventory Outstanding
Operating Cycle				4.93K
Cash Conversion Cycle				4.93K
Asset Turnover				0.06

Metric
Operating Cash Flow				4.54B
Free Cash Flow				4.50B
Cash Flow to Debt				28.82
Operating Cash Flow/Sales				1.09
Free Cash Flow Yield				0.08

Metric
Cash & Equivalents				67.98B
Accounts Receivable				-5.72B
Inventory
Goodwill
Debt to Capitalization				0.89
Debt to Assets				0.09
Current Ratio				1.11
Quick Ratio				11.54K

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue				0.02
R&D to Revenue
SG&A to Revenue				0.05